Ovarian Cancer

In this video, Ronny Drapkin, MD, discusses identifying patients at heightened risk for ovarian cancer.

In this video, Ronny Drapkin, MD, discusses known risk factors for ovarian cancer.

In this video, Ronny Drapkin, MD, discusses how PARP inhibitors changed the field of ovarian cancer treatment.

In this video, Ronny Drapkin, MD, discusses recent advancements in ovarian cancer.

In this video, Ronny Drapkin, MD, discusses challenges in diagnosing ovarian cancer.

BOSTON — People with primary ovarian insufficiency have higher risk for breast cancer and borderline increased risk for ovarian cancer compared with the general population, and risks for some cancers extend to their relatives, data show.

Endometriosis was significantly associated with higher risks for both ovarian and endometrial cancers, but was not significantly associated with cervical cancer risk, according to an analysis published in Current Oncology.

A trial investigating mirvetuximab soravtansine monotherapy in certain patients with platinum-sensitive ovarian cancer met its primary endpoint of improved objective response rate, according to the agent’s manufacturer.

CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.

SAN FRANCISCO — Nearly 20% of women of reproductive age with epithelial ovarian cancer undergo fertility-sparing surgery, which may not negatively affect overall survival, except in the case of high-grade endometrioid tumors, data show.